首页> 外文期刊>American Journal of Pathology >Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin Matrices
【24h】

Role and Localization of Urokinase Receptor in the Formation of New Microvascular Structures in Fibrin Matrices

机译:尿激酶受体在纤维蛋白基质新微血管结构形成中的作用和定位

获取原文
获取原文并翻译 | 示例
       

摘要

Fibrin or a fibrinous exudate can facilitate angiogenesis in many pathological conditions. In vitro, the outgrowth of capillary-like structures in fibrin can be mimicked by exposing human microvascular endothelial cells (hMVECs) to an angiogenic growth factor and tumor necrosis factor (TNF)-. Urokinase-type plasminogen activator (u-PA) and plasmin activities are required for this angiogenic process. This study focuses on the role and localization of the u-PA receptor (u-PAR) in newly formed microvascular structures. The u-PAR-blocking monoclonal antibody (MAb) H-2 completely inhibited the formation of capillary-like tubular structures induced by exposure of hMVECs to basic fibroblast growth factor and TNF-. This was accompanied by a several-fold increase in u-PA accumulation in the conditioned medium. The effect of MAb H-2 was not caused by blocking cellular activation by u-PA/u-PAR interaction, as the amino-terminal fragment (ATF) of u-PA, which also activates u-PAR, prevented tube formation. In addition, the inhibition by MAb H-2 was not due to an effect of the antibody on u-PAR-vitronectin binding. These data show that inhibition of tube formation can be caused not only by inhibition of u-PA or plasmin activities but also by unavailability of the u-PAR for cell-bound proteolysis. Immunohistochemical analysis showed that in in vitro angiogenesis u-PAR and u-PA were localized on the invading, tube-forming hMVECs and not on the endothelial cells that are located on top of the fibrin matrix. u-PAR and u-PA were also prominently expressed on endothelial cells of neovessels present in an atherosclerotic plaque. These data may give more insight into the role of u-PAR in repair-associated angiogenesis.
机译:纤维蛋白或纤维状渗出物可在 许多病理状况下促进血管生成。在体外,可以通过将人微血管 内皮细胞(hMVEC)暴露于血管生成生长因子和 结构的生长>肿瘤坏死因子(TNF)-。尿激酶型纤溶酶原激活物 (u-PA)和纤溶酶活性是该血管生成 过程所必需的。这项研究的重点是 u-PA受体(u-PAR)在新形成的微血管结构中的作用和定位。 u-PAR阻断单克隆抗体(MAb) H-2完全 抑制了hMVECs暴露于碱性成纤维细胞生长因子 和TNF-诱导的毛细血管样结构的形成。这伴随着 u-PA在条件培养基中的积累增加了几倍。 MAb H-2的作用不是由于u-PA / u-PAR 相互作用阻止细胞激活而引起的,因为u-PA / u-PAR 相互作用 的PA也会激活u-PAR,从而防止了管的形成。此外, 对MAb H-2的抑制不是由于抗体 对u-PAR-玻连蛋白结合的影响。这些数据表明,不仅可以通过抑制u-PA 或纤溶酶的活性,而且可以通过u-PAR 的使用来抑制管的形成。 sup>用于细胞结合蛋白水解。免疫组织化学分析显示 在体外血管生成中,u-PAR和u-PA位于 于侵入的成管hMVEC上,而不位于内皮细胞上。位于纤维蛋白基质顶部的sup>。 u-PAR和u-PA 也在动脉粥样硬化斑块中的新血管 的内皮细胞上显着表达。这些数据可能使 进一步了解u-PAR在修复相关血管生成中的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号